Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Krystal Biotech Inc..
Krystal Biotech Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Krystal Biotech Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Krystal Biotech Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Krystal Biotech Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Krystal Biotech Inc. and all latest updates of the company are provided.
The 2025 version of Krystal Biotech Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Krystal Biotech Inc.- Key Facts
2.2 Krystal Biotech Inc.- Geographic Locations
2.3 Krystal Biotech Inc.- Subsidiaries and Affiliates
2.4 Krystal Biotech Inc.- Business Divisions
2.5 Krystal Biotech Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Krystal Biotech Inc. Strategic Analysis Review
3.1 Krystal Biotech Inc.- Key Strategies
3.2 Krystal Biotech Inc.- Company Outlook Statement
3.3 Krystal Biotech Inc.- SWOT Analysis
3.3.1 Krystal Biotech Inc.- Key Strengths
3.3.2 Krystal Biotech Inc.- Key Weaknesses
3.3.3 Krystal Biotech Inc.- Potential Opportunities
3.3.4 Krystal Biotech Inc.- Potential Threats
3.4 Krystal Biotech Inc.- Key Competitors
4. Business Description of the Company
4.1 Krystal Biotech Inc.- Business Overview
4.2 Krystal Biotech Inc.- Operations by Segment
5 Products and Services Details
5.1 Krystal Biotech Inc.- Key Products
5.2 Krystal Biotech Inc.- Key Service Areas
5.3 Krystal Biotech Inc.- Key Brands
6 Company Developments
6.1 Krystal Biotech Inc.- Company History
6.2 Krystal Biotech Inc.- Latest Developments
7 Financial Analysis
7.1 Krystal Biotech Inc.- Income Statements
7.2 Krystal Biotech Inc.- Balance Sheet
7.3 Krystal Biotech Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Krystal Biotech Inc.- Direct Competitors
8.2 Krystal Biotech Inc.- Competitor Financial Ratios comparison
8.3 Krystal Biotech Inc.- Competitor Stock Charts Comparison
8.4 Krystal Biotech Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!